Boden R, Botting R, Coulson P, Spanswick G
Br J Pharmacol. 1984 May;82(1):151-4. doi: 10.1111/j.1476-5381.1984.tb16452.x.
The LD50 of pethidine was determined in mice pretreated (4 h) either with the nonselective monoamine oxidase (MAO) inhibitor, phenelzine or with clorgyline, a selective inhibitor of MAO A or deprenyl, a selective inhibitor of MAO B. Phenelzine or combined clorgyline plus deprenyl pretreatments decreased pethidine LD50. Clorgyline or deprenyl alone did not affect pethidine toxicity. Whole brain 5-hydroxytryptamine (5-HT) concentrations were measured in the pretreated mice. 5-HT levels were approximately doubled (P less than 0.001) after phenelzine or clorgyline plus deprenyl treatment, but not after clorgyline or deprenyl given alone. These results indicate that both MAO A and MAO B need to be inhibited to increase pethidine toxicity and brain 5-HT levels. They support the involvement of 5-HT in the toxic interaction between pethidine and MAO inhibitors.
在预先用非选择性单胺氧化酶(MAO)抑制剂苯乙肼、MAO A选择性抑制剂氯吉兰或MAO B选择性抑制剂司来吉兰预处理(4小时)的小鼠中测定哌替啶的半数致死量(LD50)。苯乙肼或氯吉兰与司来吉兰联合预处理降低了哌替啶的LD50。单独使用氯吉兰或司来吉兰不影响哌替啶的毒性。在预先处理的小鼠中测量全脑5-羟色胺(5-HT)浓度。苯乙肼或氯吉兰加司来吉兰处理后5-HT水平大约增加了一倍(P小于0.001),但单独给予氯吉兰或司来吉兰后未出现这种情况。这些结果表明,需要同时抑制MAO A和MAO B才能增加哌替啶毒性和脑5-HT水平。它们支持5-HT参与哌替啶与MAO抑制剂之间的毒性相互作用。